Vascular invasion in pancreatic cancer: Tumor biology or tumor topography?

Surgery (United States)

Volumn 152, Issue 3 SUPPL., 2012, Pages

  Rehders, Alexander ^a   Stoecklein, Nikolas H ^a   Güray, Ayse ^a   Riediger, Rouwen ^a   Alexander, Andrea ^a   Knoefel, Wolfram Trudo ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER PROGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TUMOR CELL; TUMOR LOCALIZATION; VASCULAR SURGERY; VASCULAR TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MESENTERIC VEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PORTAL VEIN; PROGNOSIS; SURVIVAL RATE; VASCULAR SURGICAL PROCEDURES;

EID: 84865220734     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.05.012     Document Type: Article

References (33)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisiani Global cancer statistics CA Cancer J Clin 55 2005 74 108
2. H. Riediger, T. Keck, and U. Wellner The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer J Gastrointest Surg 13 2009 1337 1344
3. T. Schnelldorfer, A.L. Ware, and M.G. Sarr Long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247 2008 456 462
4. T. Zacharias, D. Jaeck, and E. Oussoultzoglou Impact of node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas J Gastrointest Surg 11 2007 350 356
5. A. Mancuso, F. Calabro, and C.N. Sternberg Current therapies and advances in the treatment of pancreatic cancer Crit Rev Oncol/Hematol 58 2006 231 241
6. J.P. Neoptolemos, R.C. Russel, S. Bramhall UK Pancreatic Cancer Group Low mortality following resection for pancreatic and periampullary tumors in 1026 patients: UK survey of specialist pancreatic units Br J Surg 84 1997 1370 1376
7. A. Arslan, T. Buanes, and J.T. Geitung Pancreatic adenocarcinoma: MR, MR angiography and dynamic helical CT in the evaluation of vascular invasion Eur J Radiol 38 2001 151 159
8. C.P. Raut, J.F. Tseng, and C.C. Sun Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg 246 2007 52 60
9. J.G. Fortner Regional resection of cancer of the pancreas: a new surgical approach Surgery 73 1973 307 320
10. E.F. Yekebas, D. Bogoevski, and G. Cataldegirmen En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients Ann Surg 247 2008 300 309
11. P. Bachellier, H. Nakano, and P.D. Oussoultzoglou Is pancreatoduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg 182 2001 120 129
12. A. Nakao, A. Harada, and T. Nonami Clinical significance of portal invasion by pancreatic head carcinoma Surgery 117 1995 50 55
13. S. Takahashi, Y. Ogata, and T. Tsuzuki Combined resection of the pancreas and portal vein for pancreatic cancer Br. J. Surg 81 1994 1190 1193
14. L. Capussotti, P. Massucco, and D. Ribero Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy Arch Surg 138 2003 1316 1322
15. T. Nakaghori, T. Kinoshita, and M. Konishi Survival benefits of portal vein resection for pancreatic cancer Am J Surg 186 2003 149 153
16. J. Lüttges, I. Vogel, and M. Menke The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas Virchows Arch 433 1998 237 242
17. K. Shimada, T. Sano, and Y. Sakamoto Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma Ann Surg Oncol 13 2006 1569 1578
18. S.K. Reddy, D.S. Tyler, and T.N. Pappas Extended resection for pancreatic adenocarcinoma Oncologist 12 2007 654 663
19. H.P. Siriwardana, and A.K. Siriwardana Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer Br J Surg 93 2006 662 673
20. L.E. Harrison, D.S. Klimstra, and M.F. Brennan Isolated portal vein involvement in pancreatic adenocarcinoma: a contraindication for resection? Ann Surg 224 1996 342 347
21. G.M. Fuhrmann, S.D. Leach, C.A. Staley Pancreatic Tumor Study Group Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence Ann Surg 223 1996 154 162
22. H. Kurahara, S. Takao, and K. Maemura Impact of lymph node micrometastases in patients with pancreatic head cancer World J Surg 31 2007 483 490
23. P. Scheunemann, N.H. Stoecklein, and A. Rehders Occult tumor cells in lymph nodes as a predictor for tumor relapse in pancreatic adenocarcinoma Langenbecks Arch Surg 393 2008 359 365
24. K.E. Effenberger, C. Schroeder, and C. Eulenburg Disseminated tumor cells in pancreatic cancer: an independent prognosticator of disease progression and survival Int J Cancer 2011 [Epub ahead of print]
25. L.H. Sobin, and Ch Wittekind TNM classification of malignant tumors 6th. ed 2002 Wiley New York
26. P. Scheunemann, N.H. Stoecklein, and A. Rehders Frequency and prognostic significance of occult tumor cells in lymph nodes in patients with adenocarcinoma of the papilla of Vater HPB Surg 9 2007 135 139
27. N.H. Stoecklein, A. Siegmund, and P. Scheunemann Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker BMC Cancer 6 2006 135 143
28. A. Raffel, C.F. Eisenberger, and K. Cupisti Increased EpCAM expression in malignant insulinoma: potential clinical implications Eur J Endocrinol 162 2010 391 398
29. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Statist Assoc 53 1958 457 481
30. J.E. Lim, M.W. Chien, and C.C. Earle Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based linked database analysis of 396 patients Ann Surg 237 2003 74 85
31. T.A. Sohn, C.J. Yeo, and J.L. Cameron Resected adenocarcinoma of the pancreas: 616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 2000 567 579
32. J.W. Chen, M. Bhandari, and D.S. Astill Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion HPB Surg 12 2010 101 108
33. S.B. Hosch, W.T. Knoefel, and S. Metz Early lymphatic tumor cells in pancreatic cancer: frequency and prognostic significance Pancreas 15 1997 154 159